Literature DB >> 28123446

Emerging Nanomedicine Approaches to Targeting HIV-1 and Antiretroviral Therapy.

Hilliard L Kutscher1, Paras N Prasad1, Gene D Morse1, Jessica L Reynolds2.   

Abstract

Entities:  

Year:  2016        PMID： 28123446      PMCID： PMC5257175          DOI： 10.2217/fvl.15.114

Source DB:  PubMed          Journal:  Future Virol        ISSN： 1746-0794            Impact factor:   1.831


× No keyword cloud information.
  10 in total

Review 1.  Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.

Authors:  Zabrina L Brumme; Denis R Chopera; Mark A Brockman
Journal:  Curr Opin Virol       Date:  2012-08-29       Impact factor: 7.090

Review 2.  Developing strategies for HIV-1 eradication.

Authors:  Christine M Durand; Joel N Blankson; Robert F Siliciano
Journal:  Trends Immunol       Date:  2012-08-03       Impact factor: 16.687

Review 3.  Redefining the viral reservoirs that prevent HIV-1 eradication.

Authors:  Evelyn Eisele; Robert F Siliciano
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

4.  Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.

Authors:  Nagsen Gautam; Upal Roy; Shantanu Balkundi; Pavan Puligujja; Dongwei Guo; Nathan Smith; Xin-Ming Liu; Benjamin Lamberty; Brenda Morsey; Howard S Fox; Joellyn McMillan; Howard E Gendelman; Yazen Alnouti
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

Review 5.  Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

Authors:  Benson J Edagwa; Tian Zhou; JoEllyn M McMillan; Xin-Ming Liu; Howard E Gendelman
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

6.  Macrophage Targeted Nanoparticles for Antiretroviral (ARV) Delivery.

Authors:  Hilliard L Kutscher; Faithful Makita-Chingombe; Sara DiTursi; Ajay Singh; Admire Dube; Charles C Maponga; Gene D Morse; Jessica L Reynolds
Journal:  J Pers Nanomed       Date:  2015-11-14

Review 7.  Towards an HIV-1 cure: measuring the latent reservoir.

Authors:  Katherine M Bruner; Nina N Hosmane; Robert F Siliciano
Journal:  Trends Microbiol       Date:  2015-03-05       Impact factor: 17.079

8.  Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.

Authors:  Admire Dube; Jessica L Reynolds; Wing-Cheung Law; Charles C Maponga; Paras N Prasad; Gene D Morse
Journal:  Nanomedicine       Date:  2013-12-10       Impact factor: 5.307

9.  Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages.

Authors:  Mariluz Araínga; Dongwei Guo; Jayme Wiederin; Pawel Ciborowski; JoEllyn McMillan; Howard E Gendelman
Journal:  Retrovirology       Date:  2015-01-22       Impact factor: 4.602

Review 10.  Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?

Authors:  Wasim Abbas; Muhammad Tariq; Mazhar Iqbal; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2015-03-31       Impact factor: 5.048
  10 in total
  1 in total

1.  Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations.

Authors:  Faithful Makita-Chingombe; Hilliard L Kutscher; Sara L DiTursi; Gene D Morse; Charles C Maponga
Journal:  J Drug Deliv       Date:  2016-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.